Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
Alzheimer's disease (AD) represents a substantial unmet need, due to increasing prevalence in an ageing society and the absence of a disease modifying therapy. Epidemiological evidence shows a protective effect of non steroidal anti inflammatory (NSAID) drugs, and genome wide association studie...
Main Authors: | Nevado-Holgado, A, Lovestone, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Pharmaceutical composition of non-steroidal anti-inflammatory drugs
by: Basri, Mahiran, et al.
Published: (2009) -
Non-steroidal anti-inflammatory drugs for pain in women with endometriosis.
by: Allen, C, et al.
Published: (2005) -
Modelling circadian variation in the pharmacokinetics of non-steroidal anti-inflammatory drugs.
by: Aronson, J, et al.
Published: (1993) -
Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs.
by: Chan, J, et al.
Published: (2010) -
Renal disease and use of topical non-steroidal anti-inflammatory drugs.
by: O'Callaghan, C, et al.
Published: (1994)